Giovanni Grignani, MD

Candiolo Cancer Institute, FPO – IRCCS
Turin, Piemonte, Italy

Disclosure information not submitted.

Presentation(s):

• Paper 24 - MILADEMETAN VS. TRABECTEDIN IN PATIENTS WITH DEDIFFERENTIATED LIPOSARCOMA: RESULTS FROM THE PHASE 3 MANTRA STUDY

  Thursday, November 2, 2023
  4:00 PM – 5:30 PM  

• Paper 32 - IMMUNOSARC II MASTER TRIAL (PHASE II OF SUNITINIB AND NIVOLUMAB): RESULTS FROM THE VASCULAR SARCOMAS COHORT. A GEIS, ISG AND UCL STUDY.

  Friday, November 3, 2023
  9:00 AM – 10:00 AM